BlackRock Investment Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

BlackRock Investment Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,095	Closed	-$4K	–	4161
2016 Q1	$4K	Hold	4,095	–	–	﹤0.01%	3880
2015 Q4	$5K	Hold	4,095	–	–	﹤0.01%	3877
2015 Q3	$9K	Hold	4,095	–	–	﹤0.01%	3744
2015 Q2	$8K	Sell	4,095 -36,175	-90%	-$103K	﹤0.01%	3824
2015 Q1	$156K	Hold	40,270	–	–	﹤0.01%	3253
2014 Q4	$145K	Buy	40,270 +405	+1%	+$1.07K	﹤0.01%	3292
2014 Q3	$106K	Buy	39,865 +7,703	+24%	+$51.5K	﹤0.01%	3297
2014 Q2	$374K	Buy	32,162 +15,328	+91%	+$174K	﹤0.01%	3148
2014 Q1	$235K	Buy	16,834 +987	+6%	+$15.5K	﹤0.01%	3214
2013 Q4	$282K	Buy	15,847 +3,304	+26%	+$53.7K	﹤0.01%	3158
2013 Q3	$211K	Buy	+12,543	New	+$176K	﹤0.01%	3181

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM

Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return

BlackRock Investment Management's MBII Position: Q2 2016 in Review

BlackRock Investment Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2016, closing a stake of 4,095 shares — an estimated $4K sold.

BlackRock Investment Management first reported a position in MBII in Q3 2013 and held it in 11 quarters. The position peaked at $374K in Q2 2014. 24 funds tracked by Wall St. Rank hold MBII as of Q2 2016.

BlackRock Investment Management reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 4,095 Marrone Bio Innovations, Inc. shares in Q2 2016, an estimated $4K.
BlackRock Investment Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 11 quarters.
BlackRock Investment Management's Marrone Bio Innovations, Inc. position peaked at $374K in Q2 2014.
24 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.